These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3133565)

  • 1. Genentech gets patent protection for tissue plasminogen activator.
    Ezzell C
    Nature; 1988 Jun; 333(6176):790. PubMed ID: 3133565
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechnology patents. Genentech wins round two.
    Gershon D
    Nature; 1990 Apr; 344(6268):692. PubMed ID: 2109830
    [No Abstract]   [Full Text] [Related]  

  • 4. Genentech patent.
    Nature; 1988 Sep; 335(6186):105. PubMed ID: 3137476
    [No Abstract]   [Full Text] [Related]  

  • 5. Genentech stops making TPA.
    Wagner M
    Mod Healthc; 1988 Oct; 18(43):5. PubMed ID: 10325205
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent office decision puts Genentech out in front.
    Ezzell C
    Nature; 1987 Nov 12-18; 330(6144):97. PubMed ID: 3478596
    [No Abstract]   [Full Text] [Related]  

  • 7. Claims on tissue plasminogen activator.
    Crespi RS
    Nature; 1989 Jan; 337(6205):317-8. PubMed ID: 2492089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genentech falls at the last fence in race to market heart drug.
    Anderson A
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108670
    [No Abstract]   [Full Text] [Related]  

  • 9. First US patent on TPA for Oxford University.
    Ezzell C
    Nature; 1988 Jun; 333(6172):383. PubMed ID: 3131680
    [No Abstract]   [Full Text] [Related]  

  • 10. US patents in the balance.
    Ezzell C
    Nature; 1987 Jul 16-22; 328(6127):189. PubMed ID: 3110625
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug costs threaten patent protection.
    Cimons M
    Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
    [No Abstract]   [Full Text] [Related]  

  • 12. TPA patent battle rages in United Kingdom.
    Johnston K
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671
    [No Abstract]   [Full Text] [Related]  

  • 13. Genentech loses another patent dispute in court.
    Ezzell C
    Nature; 1987 Jul 30-Aug 5; 328(6129):372. PubMed ID: 3112577
    [No Abstract]   [Full Text] [Related]  

  • 14. International patent protection for HIV-related therapies: patent attorney's perspective.
    Pavento LC; Greene JL; McDonald JK
    Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug patent protection: how long is long enough?
    Sibbald B
    CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
    [No Abstract]   [Full Text] [Related]  

  • 16. Genentech awarded critical antibody patent.
    Robertson D
    Nat Biotechnol; 2002 Feb; 20(2):108. PubMed ID: 11821843
    [No Abstract]   [Full Text] [Related]  

  • 17. Wellcome versus Genentech result.
    Johnston K
    Nature; 1987 Jul 16-22; 328(6127):189. PubMed ID: 3110626
    [No Abstract]   [Full Text] [Related]  

  • 18. New battle over TPA.
    Ezzell C
    Nature; 1989 Aug; 340(6233):418. PubMed ID: 2502715
    [No Abstract]   [Full Text] [Related]  

  • 19. Growing strong. Biotechnology's new wave hopes that being first will pay off.
    Erickson D
    Sci Am; 1992 Jan; 266(1):134, 136. PubMed ID: 1734508
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.